Latest Europe News

CLINUVEL Pharmaceuticals secures Canadian marketing approval for SCENESSE®, expanding access to the only approved systemic photoprotective treatment for erythropoietic protoporphyria (EPP).

Datagate Innovation Limited reports steady 23% ARR growth despite customer churn and pricing pressure, while targeting a US$5 million ARR milestone to enhance its valuation over the next two years.

Mesoblast Limited’s Ryoncil® posted US$36 million in Q4 revenue, driving a full-year total of US$115 million, exceeding initial forecasts. The FDA-approved stem cell therapy for pediatric graft-versus-host disease shows robust uptake across US pediatric centres.

Krakatoa Resources has verified significant visual antimony mineralisation in early 2026 drilling at its Zopkhito project, advancing efforts to formalise a JORC-compliant resource estimate. Assays remain pending as the company prepares for underground sampling and metallurgical testing.

Euro Manganese has restructured its $23.5 million convertible loan with Orion into a royalty on its Chvaletice Manganese Project, enhancing financial flexibility and streamlining its capital structure ahead of project development.

EcoGraf has appointed Sven Olsson as an independent director and Peter Schuhmacher as a board advisor to bolster its European investor relations and advance its HFfree purification technology amid growing ESG demand.

Dimerix will provide continued access to its investigational drug DMX-200 for eligible patients with focal segmental glomerular sclerosis after completing the pivotal ACTION3 Phase 3 trial, supporting ongoing treatment ahead of regulatory approval.

Proteomics International has won a key US patent for its PromarkerEndo blood test, bolstering its commercial foothold in the world’s largest healthcare market. The patented technology offers a non-invasive, accurate diagnosis of endometriosis, a condition that currently takes years to detect.

European Metals Holdings has revealed preliminary testwork results indicating a potential switch to a tunnel kiln for its Cinovec Lithium Project, promising substantial capital and operating cost savings alongside a reduced carbon footprint.

Botanix Pharmaceuticals has received an Intention to Grant from the European Patent Office for a patent protecting its Sofdra applicator technology, potentially extending exclusivity in Europe until 2039.

Zoono Group has reported a 94% jump in quarterly cash receipts to NZ$975K, turning cash flow positive amid expanding commercial rollouts of its shelf-life extension technology across multiple continents.

Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.